Search results for " Small"

showing 10 items of 806 documents

Effects of cromakalim on acetylcholine release and smooth muscle contraction in guinea-pig small intestine

1989

The effects of the potassium channel opener cromakalim on smooth muscle contraction and 3H-acetyl-choline release were studied simultaneously in guinea-pig longitudinal muscle myenteric plexus preparations which had been preincubated with 3H-choline. Cromakalim (10 mumol/l) inhibited more markedly the smooth muscle contractions caused by the release of endogenous acetylcholine (via electrical stimulation or via activation of nicotine- and 5-HT3-receptors) than contractions induced by pilocarpine. Cromakalim (10 mumol/l) did not affect the release of 3H-acetylcholine evoked by electrical stimulation or by stimulation of nicotine- and 5-HT3-receptors. In contrast, the release of 3H-acetylchol…

MaleCromakalimmedicine.medical_specialtyGuinea PigsStimulationIn Vitro Techniqueschemistry.chemical_compoundIsometric ContractionInternal medicineIntestine SmallmedicineAnimalsBenzopyransPyrrolesMyenteric plexusPharmacologymusculoskeletal neural and ocular physiologyMuscle SmoothGeneral MedicineSmooth muscle contractionmusculoskeletal systemAcetylcholineElectric StimulationPotassium channelEndocrinologychemistrycardiovascular systemPotassium channel openermedicine.symptomCromakalimAcetylcholinemedicine.drugMuscle contractionNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro

2011

Glucagon-like peptide-1 (GLP-1) acts at the G protein-coupled receptor, GLP-1R, to stimulate secretion of insulin and to inhibit secretion of glucagon and gastric acid. Involvement in mucosal secretory physiology has received negligible attention. We aimed to study involvement of GLP-1 in mucosal chloride secretion in the small intestine. Ussing chamber methods, in concert with transmural electrical field stimulation (EFS), were used to study actions on neurogenic chloride secretion. ELISA was used to study GLP-1R effects on neural release of acetylcholine (ACh). Intramural localization of GLP-1R was assessed with immunohistochemistry. Application of GLP-1 to serosal or mucosal sides of fla…

MaleCytoplasmendocrine systemmedicine.medical_specialtyReceptors Vasoactive Intestinal Polypeptide Type IPhysiologyGuinea PigsScopolamineVasoactive intestinal peptideHormones and SignalingIleumIn Vitro TechniquesHexamethoniumGlucagonGlucagon-Like Peptide-1 ReceptorCholine O-AcetyltransferaseGuinea pigChloridesGlucagon-Like Peptide 1IleumPhysiology (medical)Internal medicineIntestine SmallReceptors GlucagonmedicineAnimalsNeuropeptide YSecretionIntestinal MucosaNeuronsHepatologyChemistrydigestive oral and skin physiologyElectric ConductivityGastroenterologyAcetylcholineElectric StimulationPeptide FragmentsSmall intestineElectrophysiological PhenomenaEndocrinologymedicine.anatomical_structureSomatostatinELAV ProteinsGastric acidCarbacholSomatostatinhormones hormone substitutes and hormone antagonistsVasoactive Intestinal PeptideAmerican Journal of Physiology-Gastrointestinal and Liver Physiology
researchProduct

Extraction of Entrapped Capsules from the Small Bowel by Means of Push-and-Pull Enteroscopy with the Double-Balloon Technique

2005

The new technique of push-and-pull enteroscopy using the double-balloon technique (double-balloon enteroscopy) makes it possible to remove swallowed foreign bodies causing intestinal obstruction deep in the small bowel without the need for surgical laparotomy. This report describes two cases of enteroscopic removal of entrapped capsules. In one patient with acute recurrent intestinal bleeding and recurrent abdominal pain, Crohn's disease had been suspected on capsule endoscopy. The second patient, with known Crohn's disease, was suffering from abdominal pain and underwent capsule endoscopy for investigation of the small bowel. Prior enteroclysis had not revealed stenoses in either patient. …

MaleEnteroscopymedicine.medical_specialtyAbdominal painmedicine.medical_treatmentBalloonEndoscopy Gastrointestinallaw.inventionCapsule endoscopylawLaparotomyIntestine SmallmedicineHumansDevice RemovalCapsule EndoscopesMiniaturizationbusiness.industryGastroenterologyMiddle AgedForeign Bodiesmedicine.diseaseSurgeryEndoscopes Gastrointestinalmedicine.anatomical_structureFluoroscopyAbdomenEquipment Failuremedicine.symptomForeign bodybusinessIntestinal ObstructionEndoscopy
researchProduct

Drinking water disinfection by-products, genetic polymorphisms, and birth outcomes in a european mother-child cohort study

2016

Background: We examined the association between exposure during pregnancy to trihalomethanes, the most common water disinfection by-products, and birth outcomes in a European cohort study (Health Impacts of Long-Term Exposure to Disinfection By-Products in Drinking Water). We took into account exposure through different water uses, measures of water toxicity, and genetic susceptibility. Methods: We enrolled 14,005 mothers (2002-2010) and their children from France, Greece, Lithuania, Spain, and the UK. Information on lifestyle-and water-related activities was recorded. We ascertained residential concentrations of trihalomethanes through regulatory records and ad hoc sampling campaigns and e…

MaleEpidemiology010501 environmental sciences01 natural sciencesCohort Studies0302 clinical medicinePregnancyRisk Factors030212 general & internal medicineProspective StudiesProspective cohort studyComputingMilieux_MISCELLANEOUS2. Zero hungerStatisticsPregnancy Outcome3. Good healthEuropeMaternal ExposureInfant Small for Gestational AgePremature BirthFemalemedicine.symptomCohort studyTrihalomethanesGenetic MarkersDNA Copy Number VariationsBirth weightPublic Health And Health ServicesPolymorphism Single Nucleotide03 medical and health sciencesEnvironmental healthmedicineHumans0105 earth and related environmental sciences[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthPregnancybusiness.industryDrinking WaterCase-control studyInfant NewbornOdds ratioInfant Low Birth Weightmedicine.diseaseDisinfectionLow birth weightCase-Control StudiesSmall for gestational ageGene-Environment InteractionbusinessWater Pollutants ChemicalDisinfectants
researchProduct

Isolation of Cholinergic Synaptic Vesicles from the Myenteric Plexus of Guinea-Pig Small Intestine

1980

The acetylcholine-rich myenteric plexus-longitudinal muscle preparation of the guinea-pig small intestine has been subjected to subcellular fractionation using modifications of both classical methods and that originally devised for bulk isolation of cholinergic synaptic vesicles from the electromotor nerve terminals of Torpedo marmorata by means of density gradient centrifugation in a zonal rotor. The latter method gave a vesicle fraction with the highest acetylcholine content so far recorded for a mammalian particulate fraction, 30.9 +/- S.E.M. 1.8 (5) nmol of acetylcholine . mg of protein-1. Electron-microscopical examination showed that it consisted of a homogeneous preparation of vesicl…

MaleGuinea PigsMyenteric PlexusBiologyCell FractionationBiochemistrySynaptic vesiclelaw.inventionCellular and Molecular NeurosciencelawIntestine SmallMyosinCentrifugation Density GradientmedicineAnimalsMyenteric plexusVesicleAcetylcholineMicroscopy ElectronBiochemistryBiophysicsCholinergicFemaleSynaptic VesiclesCell fractionationAcetylcholineTorpedomedicine.drugJournal of Neurochemistry
researchProduct

Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues.

2003

Abstract Mannose-binding lectin (MBL), a member of the collectin family, binds to carbohydrate structures on the surfaces of micro-organisms and may serve as a recognition molecule of the lectin pathway of complement activation. In rodents two forms, MBL-A and MBL-C, were described and shown to be products of two related, but uncoupled, genes. The liver is the main source of MBL biosynthesis. For rat MBL-A, expression has also been described in the kidney. Here we report that the two forms of murine MBL are differentially expressed in a number of nonhepatic tissues. Real-time RT-PCR revealed that the liver is the major site of expression for both MBL genes. Lower copy numbers were found in …

MaleLymphoid TissueImmunologyCollectinchemical and pharmacologic phenomenaIn situ hybridizationMannose-Binding LectinMiceIntestine SmallImmunology and AllergyAnimalsProtein IsoformsIn Situ HybridizationMannan-binding lectinMice Inbred BALB CInnate immune systembiologyLectinbacterial infections and mycosesAcquired immune systemMolecular biologyImmunohistochemistryComplement systemAnimals NewbornLiverOrgan SpecificityLectin pathwaybiology.proteinFemaleSpleenJournal of immunology (Baltimore, Md. : 1950)
researchProduct

Nicotinic and muscarinic modulation of 5-hydroxytryptamine (5-HT) release from porcine and canine small intestine

1992

Strips of porcine and canine small intestine were incubated in vitro and the release of 5-hydroxytryptamine (5-HT) was determined by HPLC with electrochemical detection. The spontaneous outflow of 5-HT from the porcine and canine small intestine largely reflects calcium-dependent 5-HT secretion from enterochromaffin cells which are under a spontaneous neuronal, excitatory input as indicated by the inhibitory effect (30-40%) of tetrodotoxin. In both species, nicotine enhanced the release of 5-HT in a concentration-dependent manner by a maximum of about 50% at 100 microM. This effect was blocked by the nicotine receptor antagonist hexamethonium, but not by the subtype-selective nicotine recep…

MaleNicotineSerotoninmedicine.medical_specialtySwineScopolamineHexamethonium CompoundsTetrodotoxinReceptors NicotinicBiologyHexamethoniumNicotine03 medical and health scienceschemistry.chemical_compoundDogs0302 clinical medicineInternal medicineIntestine SmallDrug DiscoveryMuscarinic acetylcholine receptorEnterochromaffin CellsmedicineOxotremorineAnimalsGenetics (clinical)030304 developmental biology0303 health sciencesMuscarineOxotremorineParasympatholyticsGeneral MedicineHydroxyindoleacetic AcidBungarotoxinsReceptors MuscarinicAcetylcholine3. Good healthNicotinic agonistEndocrinologyParasympathomimeticschemistryEnterochromaffin cellMolecular MedicineCalciumFemaleHexamethoniumDimethylphenylpiperazinium Iodide030217 neurology & neurosurgeryAcetylcholinemedicine.drugThe Clinical Investigator
researchProduct

Neuroprotective Properties of Mildronate, a Small Molecule, in a Rat Model of Parkinson’s Disease

2010

Previously, we have found that mildronate [3-(2,2,2-trimethylhydrazinium) propionate dihydrate], a small molecule with charged nitrogen and oxygen atoms, protects mitochondrial metabolism that is altered by inhibitors of complex I and has neuroprotective effects in an azidothymidine-neurotoxicity mouse model. In the present study, we investigated the effects of mildronate in a rat model of Parkinson’s disease (PD) that was generated via a unilateral intrastriatal injection of the neurotoxin 6-hydroxydopamine (6‑OHDA). We assessed the expression of cell biomarkers that are involved in signaling cascades and provide neural and glial integration: the neuronal marker TH (tyrosine hydroxylase); …

MaleNitric Oxide Synthase Type IIlcsh:ChemistryUbiquitinNeurotoxinlcsh:QH301-705.5Receptor Notch3SpectroscopyNeuronsReceptors NotchbiologyGlial fibrillary acidic proteinMicrofilament ProteinsGeneral MedicineComputer Science ApplicationsCell biologySubstantia NigraNitric oxide synthaseNeuroprotective Agentsmedicine.anatomical_structureBiochemistryNeurogliaNeurogliaMethylhydrazinesneuroimmunological biomarkersTyrosine 3-Monooxygenasesmall moleculeSubstantia nigraParkinson’s disease; 6-OHDA model; neuroimmunological biomarkers; mildronate; small moleculeNeuroprotectionArticleCatalysisInorganic ChemistryGlial Fibrillary Acidic ProteinmedicineAnimalsParkinson Disease SecondaryRats WistarPhysical and Theoretical ChemistryOxidopamineMolecular BiologyTyrosine hydroxylase6-OHDA modelCalcium-Binding ProteinsmildronateOrganic ChemistryCorpus StriatumRatslcsh:Biology (General)lcsh:QD1-999nervous systemParkinson’s diseasebiology.proteinBiomarkersInternational Journal of Molecular Sciences
researchProduct

Fatty acid amide hydrolase controls mouse intestinal motility in vivo.

2005

Background & Aims: Fatty acid amide hydrolase (FAAH) catalyzes the hydrolysis both of the endocannabinoids (which are known to inhibit intestinal motility) and other bioactive amides (palmitoylethanolamide, oleamide, and oleoylethanolamide), which might affect intestinal motility. The physiologic role of FAAH in the gut is largely unexplored. In the present study, we evaluated the possible role of FAAH in regulating intestinal motility in mice in vivo. Methods: Motility was measured by evaluating the distribution of a fluorescent marker along the small intestine; FAAH messenger RNA (mRNA) levels were analyzed by reverse-transcription polymerase chain reaction (RT-PCR); endocannabinoid level…

MaleOleamideCannabinoid receptormedicine.drug_classMotilityPharmacologyBiologyAmidohydrolaseschemistry.chemical_compoundOleoylethanolamideMiceFatty acid amide hydrolaseIntestine SmallmedicineAnimalsIntestine LargeRNA MessengerGastrointestinal TransitPalmitoylethanolamideMice Inbred ICRHepatologyReverse Transcriptase Polymerase Chain ReactionGastroenterologyReceptor antagonistEndocannabinoid systemKineticsnervous systemBiochemistrychemistrylipids (amino acids peptides and proteins)Gastrointestinal Motilitypsychological phenomena and processesGastroenterology
researchProduct

Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life

2020

Background: Mepolizumab (MEP) has been recently introduced to treat severe eosinophilic asthma. Trials have demonstrated a significant effectiveness in this asthma phenotype. We evaluated MEP efficacy on lung function, symptoms, asthma exacerbations, biologic markers, steroid dependence and controller treatment level in real-life. Methods: We retrospectively analyzed 134 severe asthmatics (61 males; mean age 58.3 ± 11; mean FEV1%:72 ± 21), treated with MEP for at least 6 months (mean duration:10.9 ± 3.7 months). Results: FEV1% improved significantly after MEP. Mean FEF25-75 also increased from 37.4 ± 25.4% to 47.2 ± 27.2% (p < 0.0001). Mean baseline blood eosinophil level was 712 ± 731/μ…

MaleOmalizumabFEF(25-75)step-down0302 clinical medicineMaintenance therapyAdrenal Cortex HormonesSettore MED/10Pharmacology (medical)Anti-Asthmatic Agents030212 general & internal medicinesmall airwaysAsthma exacerbationsmepolizumabMiddle AgedAnesthesiaFEF25-75CorticosteroidDrug Therapy CombinationFemalemedicine.drugPulmonary and Respiratory Medicinesevere asthmamedicine.drug_classMepolizumab Severe asthma Real-life Small airways FEF25-75 Oral corticosteroids Step-down EffectiveneseffectivenessSettore MED/10 - Malattie Dell'Apparato Respiratoriooral corticosteroidsAntibodies Monoclonal HumanizedNO03 medical and health sciencesEffectiveness FEF 25-75 Mepolizumab Oral corticosteroids Real-life Severe asthma Small airways Step-downmedicineHumansIn real lifeFEFreal-lifeAgedRetrospective StudiesBiologic markerbusiness.industryEffectivenesBiochemistry (medical)Effectiveness; FEF; 25-75; Mepolizumab; Oral corticosteroids; Real-life; Severe asthma; Small airways; Step-downAirway obstructionmedicine.diseaseAsthmaBlood Cell Countrespiratory tract diseasesAirway ObstructionEosinophils030228 respiratory systemeffectiveness; FEF(25-75); mepolizumab; oral corticosteroids; real-life; severe asthma; small airways; step-down25-75businessMepolizumab
researchProduct